Ajanta Pharma share price
You have to be logged in to add this to Watchlist.- ₹3,022.00(-3.21%)March 13, 2026 15:29:15 PM IST
- NSE
- BSE
- Vol : 163.18 K (NSE + BSE)Last 20 day avg : 143.59 K
Ajanta Pharma is trading -3.21% lower at Rs 3,022.00 as compared to its last closing price. Ajanta Pharma has been trading in the price range of 3,158.20 & 3,005.35. Ajanta Pharma has given 12.66% in this year & 4.86% in the last 5 days. Ajanta Pharma has TTM P/E ratio 34.09 as compared to the sector P/E of 24.38.There are 14 analysts who have initiated coverage on Ajanta Pharma. There are 7 analysts who have given it a strong buy rating & 6 analysts have given it a buy rating. 1 analysts have given the stock a sell rating.The company posted a net profit of 273.77 Crores in its last quarter.Listed peers of Ajanta Pharma include Divi's Laboratories (-3.37%), Dr Reddy's Laboratories (-2.10%), Torrent Pharmaceuticals (-1.30%).The Mutual Fund holding in Ajanta Pharma was at 15.49% in 31 Dec 2025. The MF holding has increased from the last quarter. The FII holding in Ajanta Pharma was at 7.97% in 31 Dec 2025. The FII holding has decreased from the last quarter.
- Overview
- Financials
- Forecast
- Technical Analysis
- Peers
- Shareholding
- About the company
- FAQ
Overview
Updated on Mar 15, 2026, 05:15 PM UTC
- BetaLow volatility0.61Beta measures a stock's volatility compared to the overall market. A beta > 1 indicates higher volatility than the market.
- Debt To EquityLower than industry0.01The debt-to-equity ratio, indicating a company's financial leverage.
- Dividend YieldHigher than industry1.80Annual dividends as a percentage of the stock price.
- P/BHigher than historical values10.28The P/B ratio shows how a stock's market price compares to its book value. It helps gauge whether a stock is undervalued or overvalued relative to its net assets.
- P/EHigher than historical values38.41Price-to-earnings ratio based on trailing 12-month earnings
- PEG RatioIndicates overvaluation3.77The PEG ratio evaluates a stock's valuation by comparing its P/E ratio to its earnings growth rate. A lower PEG suggests better value relative to growth
|
| ||||
|
| ||||
Names | Technical rating | Price | %Change | Market Cap | P/E | P/B | Dividend Yield | Debt to Equity |
|---|---|---|---|---|---|---|---|---|
| Divi's Laboratories | Bearish | 6,065.00 | -3.37 | 1,61,043.90 | 78.61 | 11.52 | 0.46 | 0.01 |
| Dr Reddy's Laboratories | Neutral | 1,291.00 | -2.10 | 1,07,645.34 | 18.63 | 3.14 | 0.63 | 2.34 |
| Torrent Pharmaceuticals | Bullish | 4,386.75 | -1.30 | 1,48,637.15 | 67.32 | 17.1 | 0.83 | 17.62 |
| Sun Pharmaceutical Industries | Bullish | 1,800.50 | -1.34 | 4,31,990.09 | 36.24 | 5.77 | 0.92 | 0.50 |
| Cipla | Bearish | 1,314.10 | -0.84 | 1,06,150.45 | 22.95 | 3.87 | 0.87 | 0.81 |
- Board Meetings
- AGM
- Dividends
- Bonus
- Split
- Rights
| Meeting Date | Purpose |
|---|---|
| 2026-01-30 | Quarterly Results |
| 2025-11-03 | Quarterly Results & Interim Dividend |
| 2025-07-28 | Quarterly Results & Others |
| 2025-04-30 | Audited Results & A.G.M. |
| 2025-01-30 | Quarterly Results |
- IndustryBiotechnology & Drugs
- ISININE031B01049
- BSE Code532331
- NSE CodeAJANTPHARM
Ajanta Pharma is trading at 3022.00 as on Fri Mar 13 2026 09:59:15. This is -3.21% lower as compared to its previous closing price of 3122.15.
The market capitalization of Ajanta Pharma is 37755.55 Cr as on Fri Mar 13 2026 09:59:15.
The average broker rating on Ajanta Pharma is Strong Buy. The breakup of analyst rating is given below -
- 7 analysts have given a strong buy rating
- 6 analysts have given a buy rating
- 0.00 analysts have given a hold rating
- 1 analysts have given a sell rating
- 0.00 analysts have given a strong sell rating
The 52 wk high for Ajanta Pharma is 3148.60 whereas the 52 wk low is 2022.05
Ajanta Pharma can be analyzed on the following key metrics -
- TTM P/E: 34.09
- Sector P/E: 24.38
- Dividend Yield: 1.80%
- D/E ratio: -
Ajanta Pharma reported a net profit of 920.39 Cr in 2025.
The Mutual Fund Shareholding was 15.49% at the end of 31 Dec 2025.